DUSP6 and neoplasm: To verify the clinical relevance of our findings, we performed immunohistochemistry of DUSP6 in an EOC tumor microarray and compared levels in serous adenocarcinoma samples (n=40) to levels in normal adjacent tissue (NAT; n=7).